{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:39:00Z","timestamp":1788345540217,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL146442"],"award-info":[{"award-number":["R01HL146442"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL149714"],"award-info":[{"award-number":["R01HL149714"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R21HL150032"],"award-info":[{"award-number":["R21HL150032"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL156526"],"award-info":[{"award-number":["R01HL156526"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL159862"],"award-info":[{"award-number":["R01HL159862"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL158076"],"award-info":[{"award-number":["R01HL158076"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL161004"],"award-info":[{"award-number":["R01HL161004"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL162120"],"award-info":[{"award-number":["R01HL162120"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Extracellular vesicles (EVs) participate in cell-to-cell communication and contribute toward homeostasis under physiological conditions. But EVs can also contribute toward a wide array of pathophysiology like cancer, sepsis, sickle cell disease, and thrombotic disorders. COVID-19 infected patients are at an increased risk of aberrant coagulation, consistent with elevated circulating levels of ultra-high molecular weight VWF multimers, D-dimer and procoagulant EVs. The role of EVs in COVID-19 related hemostasis may depend on cells of origin, vesicular cargo and size, however this is not well defined. We hypothesized that the procoagulant potential of EV isolates from COVID-19 (+) patient plasmas could be defined by thrombin generation assays. Here we isolated small EVs (SEVs) and large EVs (LEVs) from hospitalized COVID-19 (+) patient (n\u2009=\u200921) and healthy donor (n\u2009=\u200920) plasmas. EVs were characterized by flow cytometry, Transmission\u00a0electron microscopy, nanoparticle tracking analysis, plasma thrombin generation and a multi-omics approach to define coagulation potential. These data were consistent with differences in EV metabolite, lipid, and protein content when compared to healthy donor plasma isolated SEVs and LEVs. Taken together, the effect of EVs on plasma procoagulant potential as defined by thrombin generation and supported by multi-omics is enhanced in COVID-19. Further, we observe that this effect is driven both by EV size and phosphatidyl serine.<\/jats:p>","DOI":"10.1038\/s41598-022-26473-8","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:03:20Z","timestamp":1671793400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Coagulation potential and the integrated omics of extracellular vesicles from COVID-19 positive patient plasma"],"prefix":"10.1038","volume":"12","author":[{"given":"Saini","family":"Setua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiruphagaran","family":"Thangaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Dzieciatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Nemkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek R.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tori","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobi","family":"Rowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Doctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Buehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"issue":"2","key":"26473_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/v12020135","volume":"12","author":"LE Gralinski","year":"2020","unstructured":"Gralinski, L. E. & Menachery, V. D. Return of the coronavirus: 2019-nCoV. Viruses 12(2), 135 (2020).","journal-title":"Viruses"},{"issue":"3","key":"26473_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu, B. et al. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19(3), 141\u2013154 (2021).","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"26473_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura, A. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21(5), 319\u2013329 (2021).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"26473_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","volume":"17","author":"L Perico","year":"2021","unstructured":"Perico, L. et al. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat. Rev. Nephrol. 17(1), 46\u201364 (2021).","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"26473_CR5","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada, M. et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 18(7), 1738\u20131742 (2020).","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"26473_CR6","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua, G. et al. Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study. Lancet Haematol. 7(8), e575\u2013e582 (2020).","journal-title":"Lancet Haematol."},{"issue":"4","key":"26473_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N. et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18(4), 844\u2013847 (2020).","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"26473_CR8","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi, M. et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 7(6), e438\u2013e440 (2020).","journal-title":"Lancet Haematol."},{"issue":"9","key":"26473_CR9","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/jth.15016","volume":"18","author":"C Nougier","year":"2020","unstructured":"Nougier, C. et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J. Thromb. Haemost. 18(9), 2215\u20132219 (2020).","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"26473_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/ijlh.13329","volume":"43","author":"D White","year":"2021","unstructured":"White, D. et al. Evaluation of COVID-19 coagulopathy; Laboratory characterization using thrombin generation and nonconventional haemostasis assays. Int. J. Lab. Hematol. 43(1), 123\u2013130 (2021).","journal-title":"Int. J. Lab. Hematol."},{"issue":"9","key":"26473_CR11","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.3390\/cells10092293","volume":"10","author":"A D'Alessandro","year":"2021","unstructured":"D\u2019Alessandro, A. et al. Biological and clinical factors contributing to the metabolic heterogeneity of hospitalized patients with and without COVID-19. Cells 10(9), 2293 (2021).","journal-title":"Cells"},{"issue":"11","key":"26473_CR12","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1111\/jth.15509","volume":"19","author":"N Mackman","year":"2021","unstructured":"Mackman, N., Grover, S. P. & Antoniak, S. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus. J. Thromb. Haemost. 19(11), 2652\u20132658 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"26473_CR13","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Yanez-Mo","year":"2015","unstructured":"Yanez-Mo, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).","journal-title":"J. Extracell. Vesicles"},{"issue":"4","key":"26473_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel, G., D\u2019Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19(4), 213\u2013228 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"26473_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/ijms22010153","volume":"22","author":"K Thangaraju","year":"2020","unstructured":"Thangaraju, K. et al. Extracellular vesicles from red blood cells and their evolving roles in health, coagulopathy and therapy. Int. J. Mol. Sci. 22(1), 153 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"26473_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/cells8070727","volume":"8","author":"LM Doyle","year":"2019","unstructured":"Doyle, L. M. & Wang, M. Z. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8(7), 727 (2019).","journal-title":"Cells"},{"issue":"10","key":"26473_CR17","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/cells10102617","volume":"10","author":"VR da Costa","year":"2021","unstructured":"da Costa, V. R. et al. Exosomes in the tumor microenvironment: From biology to clinical applications. Cells 10(10), 2617 (2021).","journal-title":"Cells"},{"issue":"11","key":"26473_CR18","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/labinvest.2010.152","volume":"90","author":"HC Anderson","year":"2010","unstructured":"Anderson, H. C., Mulhall, D. & Garimella, R. Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest. 90(11), 1549\u20131557 (2010).","journal-title":"Lab Invest."},{"issue":"3","key":"26473_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/vaccines7030102","volume":"7","author":"L Urbanelli","year":"2019","unstructured":"Urbanelli, L. et al. The role of extracellular vesicles in viral infection and transmission. Vaccines (Basel) 7(3), 102 (2019).","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"26473_CR20","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1042\/CS20200623","volume":"134","author":"JM Inal","year":"2020","unstructured":"Inal, J. M. Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy. Clin. Sci. (Lond.) 134(12), 1301\u20131304 (2020).","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6","key":"26473_CR21","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/jcm9061651","volume":"9","author":"B Marchandot","year":"2020","unstructured":"Marchandot, B. et al. COVID-19 related coagulopathy: A distinct entity?. J. Clin. Med. 9(6), 1651 (2020).","journal-title":"J. Clin. Med."},{"key":"26473_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104422","volume":"85","author":"M Hassanpour","year":"2020","unstructured":"Hassanpour, M. et al. The role of extracellular vesicles in COVID-19 virus infection. Infect. Genet. Evol. 85, 104422 (2020).","journal-title":"Infect. Genet. Evol."},{"issue":"7","key":"26473_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/intimm\/dxh267","volume":"17","author":"MP Caby","year":"2005","unstructured":"Caby, M. P. et al. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17(7), 879\u2013887 (2005).","journal-title":"Int. Immunol."},{"issue":"8","key":"26473_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12112","volume":"10","author":"Z Troyer","year":"2021","unstructured":"Troyer, Z. et al. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies. J. Extracell. Vesicles 10(8), e12112 (2021).","journal-title":"J. Extracell. Vesicles"},{"issue":"7","key":"26473_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s42255-021-00425-4","volume":"3","author":"SM Lam","year":"2021","unstructured":"Lam, S. M. et al. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat. Metab. 3(7), 909\u2013922 (2021).","journal-title":"Nat. Metab."},{"issue":"6","key":"26473_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41419-021-03816-3","volume":"12","author":"K Mao","year":"2021","unstructured":"Mao, K. et al. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery. Cell Death Dis. 12(6), 541 (2021).","journal-title":"Cell Death Dis."},{"issue":"2","key":"26473_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cmet.2020.06.016","volume":"32","author":"JW Song","year":"2020","unstructured":"Song, J. W. et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 32(2), 188\u2013202 (2020).","journal-title":"Cell Metab."},{"key":"26473_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.632290","volume":"8","author":"E Barberis","year":"2021","unstructured":"Barberis, E. et al. Circulating exosomes are strongly involved in SARS-CoV-2 infection. Front. Mol. Biosci. 8, 632290 (2021).","journal-title":"Front. Mol. Biosci."},{"issue":"19","key":"26473_CR29","doi-asserted-by":"publisher","first-page":"10467","DOI":"10.3390\/ijms221910467","volume":"22","author":"FA Alzahrani","year":"2021","unstructured":"Alzahrani, F. A. et al. Untargeted metabolic profiling of extracellular vesicles of SARS-CoV-2-infected patients shows presence of potent anti-inflammatory metabolites. Int. J. Mol. Sci. 22(19), 10467 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"26473_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/cells10010085","volume":"10","author":"G Cappellano","year":"2021","unstructured":"Cappellano, G. et al. Circulating platelet-derived extracellular vesicles are a hallmark of Sars-Cov-2 infection. Cells 10(1), 85 (2021).","journal-title":"Cells"},{"key":"26473_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103369","volume":"67","author":"C Balbi","year":"2021","unstructured":"Balbi, C. et al. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection. EBioMedicine 67, 103369 (2021).","journal-title":"EBioMedicine"},{"issue":"2","key":"26473_CR32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/ATVBAHA.120.315547","volume":"41","author":"A Rosell","year":"2021","unstructured":"Rosell, A. et al. Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality-brief report. Arterioscler. Thromb. Vasc. Biol. 41(2), 878\u2013882 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"26473_CR33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1182\/bloodadvances.2020003308","volume":"5","author":"C Guervilly","year":"2021","unstructured":"Guervilly, C. et al. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv. 5(3), 628\u2013634 (2021).","journal-title":"Blood Adv."},{"issue":"9","key":"26473_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12117","volume":"10","author":"B Krishnamachary","year":"2021","unstructured":"Krishnamachary, B. et al. Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity. J. Extracell. Vesicles 10(9), e12117 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"26473_CR35","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.120.317703","volume":"127","author":"Y Zaid","year":"2020","unstructured":"Zaid, Y. et al. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ. Res. 127, 1404\u20131408 (2020).","journal-title":"Circ. Res."},{"issue":"1","key":"26473_CR36","doi-asserted-by":"publisher","first-page":"1454777","DOI":"10.1080\/20013078.2018.1454777","volume":"7","author":"T Nielsen","year":"2018","unstructured":"Nielsen, T. et al. Investigation of procoagulant activity in extracellular vesicles isolated by differential ultracentrifugation. J. Extracell. Vesicles 7(1), 1454777 (2018).","journal-title":"J. Extracell. Vesicles"},{"issue":"11","key":"26473_CR37","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.3390\/ijms20112840","volume":"20","author":"M Zara","year":"2019","unstructured":"Zara, M. et al. Biology and role of extracellular vesicles (EVs) in the pathogenesis of thrombosis. Int. J. Mol. Sci. 20(11), 2840 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"26473_CR38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fcell.2020.00298","volume":"8","author":"C Tripisciano","year":"2020","unstructured":"Tripisciano, C. et al. Extracellular vesicles derived from platelets, red blood cells, and monocyte-like cells differ regarding their ability to induce factor XII-dependent thrombin generation. Front. Cell Dev. Biol. 8, 298 (2020).","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"26473_CR39","first-page":"553","volume":"96","author":"HC Hemker","year":"2006","unstructured":"Hemker, H. C. et al. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb. Haemost. 96(5), 553\u2013561 (2006).","journal-title":"Thromb. Haemost."},{"issue":"1","key":"26473_CR40","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1038\/s41598-020-60436-1","volume":"10","author":"ID Tarandovskiy","year":"2020","unstructured":"Tarandovskiy, I. D. et al. Interspecies comparison of simultaneous thrombin and plasmin generation. Sci. Rep. 10(1), 3885 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"26473_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11239-019-01869-y","volume":"48","author":"ID Tarandovskiy","year":"2019","unstructured":"Tarandovskiy, I. D. et al. Contradictory to its effects on thrombin, C1-inhibitor reduces plasmin generation in the presence of thrombomodulin. J. Thromb. Thrombolysis 48(1), 81\u201387 (2019).","journal-title":"J. Thromb. Thrombolysis"},{"key":"26473_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1172\/jci.insight.148382","volume":"6","author":"S Kumar","year":"2021","unstructured":"Kumar, S. et al. Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages. JCI Insight 6, 21 (2021).","journal-title":"JCI Insight"},{"key":"26473_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4939-9236-2_2","volume":"1978","author":"T Nemkov","year":"2019","unstructured":"Nemkov, T. et al. High-throughput metabolomics: Isocratic and gradient mass spectrometry-based methods. Methods Mol. Biol. 1978, 13\u201326 (2019).","journal-title":"Methods Mol. Biol."},{"issue":"W1","key":"26473_CR44","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49(W1), W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"26473_CR45","doi-asserted-by":"publisher","first-page":"6522","DOI":"10.1038\/s41598-017-03262-2","volume":"7","author":"C Tripisciano","year":"2017","unstructured":"Tripisciano, C. et al. Different potential of extracellular vesicles to support thrombin generation: Contributions of phosphatidylserine, tissue factor, and cellular origin. Sci. Rep. 7(1), 6522 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"26473_CR46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","volume":"41","author":"EG Bouck","year":"2021","unstructured":"Bouck, E. G. et al. COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity. Arterioscler. Thromb. Vasc. Biol. 41(1), 401\u2013414 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"26473_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","volume":"13","author":"P Wolf","year":"1967","unstructured":"Wolf, P. The nature and significance of platelet products in human plasma. Br. J. Haematol. 13(3), 269\u2013288 (1967).","journal-title":"Br. J. Haematol."},{"issue":"5","key":"26473_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0163-7827(03)00025-0","volume":"42","author":"BR Lentz","year":"2003","unstructured":"Lentz, B. R. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog. Lipid Res. 42(5), 423\u2013438 (2003).","journal-title":"Prog. Lipid Res."},{"key":"26473_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fcvm.2020.00015","volume":"7","author":"EC Reddy","year":"2020","unstructured":"Reddy, E. C. & Rand, M. L. Procoagulant phosphatidylserine-exposing platelets in vitro and in vivo. Front. Cardiovasc. Med. 7, 15 (2020).","journal-title":"Front. Cardiovasc. Med."},{"key":"26473_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-016-0328-9","volume":"35","author":"L Zhao","year":"2016","unstructured":"Zhao, L. et al. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients. J. Exp. Clin. Cancer Res. 35, 54 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"26473_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06033","volume":"7","author":"SE Lind","year":"2021","unstructured":"Lind, S. E. Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation. Heliyon 7(1), e06033 (2021).","journal-title":"Heliyon"},{"issue":"1","key":"26473_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1172\/JCI111672","volume":"75","author":"PF Franck","year":"1985","unstructured":"Franck, P. F. et al. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J. Clin. Invest. 75(1), 183\u2013190 (1985).","journal-title":"J. Clin. Invest."},{"key":"26473_CR53","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fcell.2020.00597","volume":"8","author":"M F\u00f6ller","year":"2020","unstructured":"F\u00f6ller, M. & Lang, F. Ion transport in eryptosis, the suicidal death of erythrocytes. Front. Cell Dev. Biol. 8, 597 (2020).","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"26473_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/jcp.1041420218","volume":"142","author":"M Rahm","year":"1990","unstructured":"Rahm, M. & Sejersen, T. c-fos reduces growth factor requirements for mitogenic stimulation of L6 rat myoblasts. J. Cell Physiol. 142(2), 352\u2013358 (1990).","journal-title":"J. Cell Physiol."},{"issue":"1","key":"26473_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1172\/JCI4985","volume":"104","author":"V Combes","year":"1999","unstructured":"Combes, V. et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 104(1), 93\u2013102 (1999).","journal-title":"J. Clin. Invest."},{"issue":"11","key":"26473_CR56","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1111\/jth.15107","volume":"18","author":"F Denorme","year":"2020","unstructured":"Denorme, F. et al. COVID-19 patients exhibit reduced procoagulant platelet responses. J. Thromb. Haemost. 18(11), 3067\u20133073 (2020).","journal-title":"J. Thromb. Haemost."},{"issue":"34","key":"26473_CR57","doi-asserted-by":"publisher","first-page":"24764","DOI":"10.1074\/jbc.M113.474023","volume":"288","author":"P Dr\u00fccker","year":"2013","unstructured":"Dr\u00fccker, P. et al. Lipid segregation and membrane budding induced by the peripheral membrane binding protein annexin A2. J. Biol. Chem. 288(34), 24764\u201324776 (2013).","journal-title":"J. Biol. Chem."},{"issue":"11","key":"26473_CR58","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1021\/acs.jproteome.0c00365","volume":"19","author":"A D'Alessandro","year":"2020","unstructured":"D\u2019Alessandro, A. et al. Serum proteomics in COVID-19 patients: Altered coagulation and complement status as a function of IL-6 level. J. Proteome Res. 19(11), 4417\u20134427 (2020).","journal-title":"J. Proteome Res."},{"key":"26473_CR59","doi-asserted-by":"crossref","unstructured":"Thomas, T. et al. Evidence for structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. medRxiv (2020).","DOI":"10.1101\/2020.06.29.20142703"},{"issue":"15","key":"26473_CR60","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1182\/bloodadvances.2019000605","volume":"3","author":"HL Howie","year":"2019","unstructured":"Howie, H. L. et al. Differences in Steap3 expression are a mechanism of genetic variation of RBC storage and oxidative damage in mice. Blood Adv. 3(15), 2272\u20132285 (2019).","journal-title":"Blood Adv."},{"issue":"7","key":"26473_CR61","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/j.1538-7836.2012.04758.x","volume":"10","author":"PE Van Der Meijden","year":"2012","unstructured":"Van Der Meijden, P. E. et al. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J. Thromb. Haemost. 10(7), 1355\u20131362 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"26473_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.817305","volume":"8","author":"K Thangaraju","year":"2021","unstructured":"Thangaraju, K. et al. The impact of age and BMI on the VWF\/ADAMTS13 axis and simultaneous thrombin and plasmin generation in hospitalized COVID-19 patients. Front. Med. (Lausanne) 8, 817305 (2021).","journal-title":"Front. Med. (Lausanne)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26473-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T23:00:26Z","timestamp":1728601226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26473-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["26473"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-26473-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AD and TN are founders of Omix Technologies Inc, and AD is scientific advisory board member for Hemanext Inc and Macopharma Inc. The other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22191"}}